Search & Analyze

Metropolis Healthcare Ltd.

546.00−8.00 (−1.44%)

BSE · 30 Oct, 4:01 PM

: ₹11,309.87 Cr
: 56.09
: 1,644
: ₹556.40 - ₹542.75
: ₹608.95 - ₹413.00

Metropolis Healthcare Ltd. (METROPOLIS) share price closed at ₹546.00 on the BSE on Friday, October 30, 2026, down by 1.44% from its of ₹554.00. In that session METROPOLIS reached a of 556.40 and of 542.75. The for the session was 547.22. The stands at 561.35 and is at 521.16. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹556.00

₹554.00

₹547.22

₹561.35

Price 2.73% below

₹521.16

Price 4.77% above

Key Fundamentals

: 11,309.87 Cr₹11.31 Thousand Crore
: 9.72
: 56.09
: 7.25
: 75.15
: 445.45 Cr₹445.45 Crore
: 0.92 %
Sector
Industry: Hospital & Healthcare Services
: 13.53
: 0.01

Industry Comparison

Ratio	Company	Sector
	56.09	44.77
	0.01	0.20
	7.25	4.61
	1.24	1.81
	0.92 %	0.11 %
Operating Margin	24.57 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,400.00	57.80	1,20,779.11	0.24	610.40	38.41%	7,043.50	20.56%	21.73
MANIPALHOS MANIPALHOS	668.45	98.54	87,926.39	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
MAXHEALTH MAXHEALTH	860.00	60.63	83,706.13	0.23	414.45	-15.64%	2,569.21	20.31%	14.97
ASTERDM ASTERDM	680.40	186.93	59,308.59	0.44	29.28	-68.70%	1,310.68	21.60%	16.22
FORTIS FORTIS	769.80	55.46	58,116.68	0.13	272.80	2.26%	2,545.03	17.46%	14.07
NH NH	1,700.00	43.06	34,741.34	0.26	301.15	16.50%	2,843.99	73.01%	16.20
MEDANTA MEDANTA	1,265.00	61.35	34,013.01	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
Metropolis Healthcare Ltd. METROPOLIS	546.00	56.09	11,309.87	0.92	56.88	25.72%	450.22	16.62%	20.03

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	331.00	313.36	349.79	322.77	345.29	386.06	429.19	405.91	424.68	450.22
Expenses	251.02	234.54	259.91	250.76	283.00	296.31	320.97	311.06	316.66	339.02
	79.98	78.81	89.88	72.01	62.30	89.76	108.22	94.85	108.02	111.19
	24.16%	25.15%	25.69%	22.31%	18.04%	23.25%	25.22%	23.37%	25.44%	24.70%
	2.54	2.46	3.13	2.56	6.97	7.52	0.89	-0.08	8.27	5.10
Interest	5.57	4.65	4.79	4.53	4.60	5.20	5.68	5.73	7.93	6.18
	26.42	25.54	26.82	27.70	28.63	30.85	32.41	31.88	38.59	32.40
	50.53	51.08	61.40	42.34	36.04	61.23	71.03	57.16	69.76	77.71
	27.72%	25.39%	23.94%	25.65%	18.90%	26.11%	25.53%	26.37%	26.95%	26.80%
	36.41	37.95	46.52	31.36	29.14	45.06	52.67	41.39	50.90	56.67
	7.11	7.41	9.08	6.12	5.63	8.70	10.17	7.99	2.46	2.73

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	1,228.34	1,148.21	1,207.71	1,331.20	1,645.85
Operating Income (Net)	1,228.34	1,148.21	1,207.71	1,331.20	1,645.85
EXPENDITURE :
Cost of Medicines and Consumables	276.02	253.26	242.57	268.68	324.52
Power & Fuel Cost	14.73	14.43	16.20	19.24	20.30
Employee Cost	233.17	252.73	275.78	313.75	377.36
Hospital Operation Expenses	48.35	31.30	46.05	50.08	79.73
Selling, Administration and Other Expenses	300.57	289.77	307.81	353.15	400.83
Miscellaneous Expenses	9.83	15.60	31.37	17.99	38.79
	882.67	857.10	919.78	1,022.90	1,241.52
Operating Profit (Excl OI)	345.66	291.11	287.93	308.31	404.32
	20.03	17.46	9.12	15.11	26.47
	365.70	308.57	297.05	323.42	430.79
Interest	25.02	31.85	27.89	23.89	28.90
PBDT	340.67	276.72	269.16	299.53	401.89
	63.22	89.22	94.47	108.68	133.72
Profit Before Taxation & Exceptional Items	277.45	187.50	174.69	190.85	268.17
Exceptional Income / Expenses	15.90				-8.99
	293.35	187.50	174.69	190.85	259.18
Provision for Tax	78.67	44.11	46.23	45.34	67.99
	214.69	143.39	128.46	145.51	191.18
Extra items				0.00	0.00
Minority Interest	-0.50	-0.51	-0.64	-0.55	-1.16
Consolidated Net Profit	214.18	142.88	127.82	144.97	190.02
Profit Balance B/F	511.21	682.09	782.36	888.03	1,031.38
Appropriations	725.39	824.97	910.18	1,032.99	1,221.39
Equity Dividend %	400.00%	400.00%	200.00%		250.00%
	41.86	27.90	24.95	27.99	9.17
Adjusted EPS	10.46	6.98	6.24	7.00	9.17

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	10.23	10.24	10.25	10.36	41.47
Share Warrants & Outstandings	11.80	7.35	7.73	7.92	10.92
Total Reserves	864.17	970.64	1,078.18	1,312.69	1,460.77
Reserve excluding Revaluation Reserve	864.17	970.64	1,078.18	1,312.69	1,460.77
Revaluation reserve			0.00
	886.20	988.23	1,096.16	1,330.97	1,513.16
Minority Interest	1.97	2.48	3.12	3.67	11.39
Secured Loans	158.68	28.61		5.27
Deferred Tax Assets / Liabilities	76.89	71.35	67.41	91.26	98.46
Other Long Term Liabilities	83.52	126.05	119.07	106.89	139.69
Long Term Provisions	173.80	190.65	186.97	240.38	190.98
Total Non-Current Liabilities	492.88	416.66	373.45	443.80	429.13
Trade Payables	103.21	94.08	99.44	125.86	129.42
Other Current Liabilities	84.26	101.52	119.68	140.24	125.31
Short Term Borrowings	99.87	50.44			18.73
Short Term Provisions	76.52	56.80	56.35	221.82	297.61
Total Current Liabilities	363.85	302.83	275.48	487.91	571.08
Total Liabilities	1,744.90	1,710.20	1,748.20	2,266.35	2,524.76
Gross Block	1,223.49	1,344.29	1,493.43	1,876.92	2,163.87
Less: Accumulated Depreciation	164.56	223.63	316.37	429.96	562.77
	1,058.93	1,120.67	1,177.06	1,446.96	1,601.09
Non Current Investments	1.75	1.75	1.75	1.75	1.75
Long Term Investment	1.75	1.75	1.75	1.75	1.75
Long Term Loans & Advances	206.61	226.36	218.73	271.71	215.13
Other Non Current Assets	16.40	1.32	5.23	6.41	1.12
Total Non-Current Assets	1,289.47	1,369.61	1,402.77	1,726.83	1,819.10
Currents Investments	13.75	13.06	53.07	69.24	140.65
Inventories	51.11	44.59	38.69	47.84	45.49
Sundry Debtors	135.49	121.89	126.28	147.95	170.29
Cash and Bank	166.94	93.19	71.22	49.02	62.32
Other Current Assets	9.81	9.39	7.45	10.96	13.30
Short Term Loans and Advances	78.33	58.48	48.71	214.51	273.63
Total Current Assets	455.42	340.60	345.43	539.52	705.67
Net Current Assets (Including Current Investments)	91.57	37.76	69.96	51.61	134.59
Total Assets	1,744.90	1,710.20	1,748.20	2,266.35	2,524.76
	4.20	3.37	4.73	6.18	10.08
Total Debt	258.55	79.05	0.00	14.19	18.73
	170.88	191.54	212.47	255.41	72.46
Adjusted Book Value	42.72	47.89	53.12	63.85	72.46

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	293.35	187.50	174.69	190.85	259.18
Adjustment	58.83	104.06	121.31	131.58	190.22
Changes In working Capital	-16.40	7.11	5.45	-15.71	-53.22
Cash Flow after changes in Working Capital	335.79	298.67	301.45	306.72	396.18
Cash Flow from Operating Activities	253.27	247.09	264.07	262.75	350.70
Cash Flow from Investing Activities	-737.57	46.79	-89.41	-201.06	-223.13
Cash Flow from Financing Activitie	162.52	-292.33	-181.20	-86.63	-115.29
Net Cash Inflow / Outflow	-321.78	1.56	-6.54	-24.94	12.28
Opening Cash & Cash Equivalents	386.59	65.98	68.83	62.62	39.48
Cash & Cash Equivalent on Amalgamation / Take over / Merger	2.53			0.82	0.57
Effect of Foreign Exchange Fluctuations	-1.36	1.30	0.33	0.98	2.46
Closing Cash & Cash Equivalent	65.98	68.83	62.62	39.48	54.78

Ratios

Valuation

56.09

7.25

25.29

6.61

9.72

75.15

Profitability

13.53

20.03

7.98

24.57

11.62

Leverage & Liquidity

0.01

1.24

9.97

Returns

0.92

0.69

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	49.62	49.43	49.40	48.89	48.89	48.89	48.88	48.87	48.86	47.82
	45.68	46.58	46.73	45.59	45.23	45.62	46.42	46.22	46.15	47.16
	4.70	3.99	3.87	5.52	5.88	5.49	4.71	4.91	4.99	5.02
	50.38	50.57	50.60	51.10	51.11	51.11	51.12	51.13	51.14	52.18
No. of Shareholders	58,108	51,852	48,572	49,293	50,015	47,846	46,670	49,175	50,636	50,592

Mutual Funds Invested(72)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 63 active funds hold 32.95% in Metropolis Healthcare Ltd., contributing to ₹3.70K Cr of holdings

Fund				As of
HD HDFC Focused Fund - Growth - Direct PlanEquity - Focused Fund	368.36	1.39	68,00,000	Sep '26
HD HDFC Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	352.11	0.32	65,00,000	Sep '26
KO Kotak Small Cap Fund - Growth - Direct PlanSmall cap Fund	345.60	1.81	63,79,864	Sep '26
FT Franklin India Small Cap Fund - Growth - Direct PlanSmall cap Fund	272.18	1.91	50,24,465	Sep '26
NI Nippon India Small Cap Fund - Growth - Direct PlanSmall cap Fund	248.17	0.31	45,81,344	Sep '26
FT Franklin India Opportunities Fund - Growth - Direct PlanEquity - Thematic Fund - Other	218.93	2.29	40,41,445	Sep '26
HD HDFC ELSS - Tax Saver Fund - Growth - Direct PlanEquity - ELSS - Tax Saver Fund	173.34	1.16	32,00,000	Sep '26
CR Canara Robeco Small Cap Fund - Growth - Direct PlanSmall cap Fund	163.12	1.17	30,11,297	Sep '26
AB Aditya Birla Sun Life Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	151.68	0.54	28,00,000	Sep '26
HD HDFC Aggressive Hybrid Fund - Growth - Direct PlanHybrid - Aggressive Hybrid Fund	132.80	0.63	24,51,504	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-28	Board Meeting	Quarterly Results & Interim Dividend
2026-07-28	AGM
2026-07-28	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)
2026-08-13	Duru Shah Family Trust	13-Aug-26	Market	1,050,000
2026-08-13	Metz Advisory LLP	13-Aug-26	Market	1,050,000

Sector Overview

HealthcareHospital & Healthcare Services

Metropolis Healthcare Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Sushil Shah

Non Independent & Non Executive Director

—

Ameera Shah

Chairperson

₹6.15 Cr

Mar '26

Surendran Chemmenkotil

Managing Director

—

Hemant Sachdev

Non Independent & Non Executive Director

—

Aparna Rajadhyaksha

Non Independent & Non Executive Director

—

Vivek Gambhir